Having chosen the path of reimbursement for homeopathy, Social Security is affected by the sales volumes of the Boiron laboratory, which complains of a deficit of over 100 million euros. As a result, after eliminating more than 500 jobs in 2021, the company now expects 145 new cuts in France.
“The volumes were divided by three in five years,” indicates the group, which will close four distribution sites – Clermont-Ferrand, Dijon, Reims and Sophia-Antipolis – and reduce its workforce in eight other cities, also affecting 32 jobs in medical examination. This series of closures highlights a shift in government and society: long-subsidized homeopathy is encountering increased resistance and collapsing.
As AFP points out, Social Security previously reimbursed these treatments at 65%. But the government, following the recommendations of the High Health Authority, put an end to this practice in 2021 – in the midst of a health crisis -, deeming it ineffective. This decision is part of a series of attacks against alternative (or alternative) medicine, in favor of allopathic medicine.
While Boiron tries to limit the damage by encouraging voluntary departures and early retirements, the debate around homeopathy remains lively. While some point to it as a symbol of unnecessary public health spending, still others defend it.
How is the perception of homeopathy shifting among healthcare professionals and the general public in France?
Interview: The Future of Homeopathy in France – Insights from Dr. Louise Bertrand, Homeopathic Medicine Expert
Time.news Editor: Welcome, Dr. Bertrand. The recent developments concerning the Boiron laboratory and the dismantling of homeopathy reimbursement by Social Security have stirred significant discussions. Can you explain how these changes are impacting the homeopathy industry in France?
Dr. Louise Bertrand: Thank you for having me. The situation is deeply concerning. Boiron, one of the largest manufacturers of homeopathic products, reported a staggering deficit of over 100 million euros, primarily due to a significant reduction in sales volumes—down to a third compared to five years ago. This is alarming not only for Boiron but for the entire homeopathy industry, which supports thousands of jobs and offers a specific type of care to many patients.
Time.news Editor: You mentioned the job cuts at Boiron. They’ve recently announced over 145 positions will be eliminated. What does this indicate about the future of homeopathic medicine in France?
Dr. Louise Bertrand: The planned job cuts and closures of distribution sites are clear indicators of a troubling shift. The decision by the French government to stop reimbursing homeopathic treatments, labeling them as ineffective, reflects a broader societal trend favoring allopathic medicine. This not only threatens the sustainability of companies like Boiron but also raises questions about the availability of alternative therapies for the public moving forward.
Time.news Editor: The government’s decision follows the recommendations of the High Health Authority, suggesting homeopathy’s effectiveness is under scrutiny. How has the perception of homeopathy evolved among healthcare professionals and the public?
Dr. Louise Bertrand: The perception of homeopathy is indeed changing. Many healthcare professionals now prioritize evidence-based medicine and support the government’s decision. However, a significant portion of the public still believes in the benefits of homeopathy, often viewing it as a complementary option to conventional treatments. This division creates a contentious debate about the role of alternative medicine in our healthcare system.
Time.news Editor: Some argue that homeopathy represents unnecessary public health spending. What is your counterargument?
Dr. Louise Bertrand: It’s essential to recognize that many patients choose homeopathy not as a substitute but as a complement to traditional medicine. Homeopathy can help manage chronic conditions and improve overall well-being, which might reduce reliance on more costly treatments down the line. Moreover, cutting down on homeopathy could lead to increased healthcare costs elsewhere if patients resort to more expensive allopathic treatments.
Time.news Editor: As someone deeply involved in this sector, what practical advice would you give to patients who are concerned about access to homeopathic treatments amid these changes?
Dr. Louise Bertrand: Patients should advocate for their preferences in healthcare. Seeking practitioners who respect both homeopathic and conventional approaches is crucial. Additionally, engaging with local health authorities and participating in discussions about the value of alternative medicine can help influence future policies. Building community support through platforms dedicated to alternative therapies can also provide a sense of solidarity and promote awareness.
Time.news Editor: Thank you, Dr. Bertrand, for shedding light on the implications of these changes in the homeopathy landscape. It’s clear that this dialog is far from over, and the future of homeopathic medicine in France will continue to evolve.
Dr. Louise Bertrand: Thank you for addressing this vital issue. Open discussions around health care choices are paramount for ensuring all patients have access to the treatments that work best for them.